Adherence to biologic disease-modifying antirheumatic drugs in adult patients with rheumatic diseases-Reference-Cited by-同舟云学术

Adherence to biologic disease-modifying antirheumatic drugs in adult patients with rheumatic diseases

Published:2021-09 Issue:5 Volume:76 Page:467-474
ISSN:0040-5957
Container-title:Therapies
language:en
Short-container-title:Therapies

Author:

Fazaa Alia,Makhlouf Yasmine,Ben Ouhiba Amad,Miladi Saoussen,Sellami Mariem,Ouenniche Kmar,Souabni Leila,Kassab Salma,Chekili Selma,Zakraoui Leith,Ben Abdelghani Kawther,Laatar Ahmed

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference29 articles.

1. New era of treatment with biologics in rheumatology – is it time to shift paradigms in treatment with biologics?;Felis-Giemza;Reumatologia,2019

2. Wnt signaling and biological therapy in rheumatoid arthritis and spondyloarthritis;Cici;Int J Mol Sci,2019

3. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012;Furst;Ann Rheum Dis,2013

4. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative;Aletaha;Ann Rheum Dis,2010

5. The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection;Rudwaleit;Ann Rheum Dis,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open‐Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission;Arthritis & Rheumatology;2024-01-25